Chimerix (NASDAQ: CMRX) reported Q3 EPS of ($0.70), $0.11 worse than the analyst estimate of ($0.59). Revenue for the quarter came in at $2.27 million versus the consensus estimate of $5.01 million.

For earnings history and earnings-related data on Chimerix (CMRX) click here.